Free Trial
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$132.73 +1.52 (+1.16%)
(As of 12/20/2024 05:31 PM ET)

About iShares Biotechnology ETF (NASDAQ:IBB)

Key Stats

Today's Range
$130.51
$134.02
50-Day Range
$131.21
$148.85
52-Week Range
$123.60
$150.57
Volume
2.00 million shs
Average Volume
1.46 million shs
Market Capitalization
$6.70 billion
Assets Under Management
$6.87 billion
Dividend Yield
0.38%
Net Expense Ratio
0.45%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.45%0.57%0.55%0.50%0.52%
Other Expenses0.00%0.30%0.49%0.41%0.53%
Total Expense0.45%0.70%0.71%0.64%0.71%
Fee Waiver0.00%-0.45%-0.51%-0.31%-0.56%
Net Expense0.45%0.61%0.61%0.57%0.59%
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

Stethoscope, bunch dollars , concept expensive medicine
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
iShares Biotechnology ETF: Playing Defense
See More Headlines

IBB ETF - Frequently Asked Questions

iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB stock has decreased by 2.3% and is now trading at $132.73.
View the best growth stocks for 2024 here
.

iShares Biotechnology ETF's stock split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were issued to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Top institutional investors of iShares Biotechnology ETF include BNP Paribas Financial Markets (4.75%), Commerce Bank (1.47%), Healthcare of Ontario Pension Plan Trust Fund (1.32%) and Main Management ETF Advisors LLC (1.18%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
ICE Biotechnology Index (TR) (USD)
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
217

Fund Statistics

Assets Under Management
$6.87 billion
Average Daily Volume
$1.51 million
Discount/Premium
-0.09%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
2,250
Put Options
1,428
Call Options
822
Short Interest
11,260,000 shs

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$614.00
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure


This page (NASDAQ:IBB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners